Breathtaking Agricultural Biotechnology Momentum: Ceres (CER

New Post Public Reply Private Reply Replies (0) Message Board
riddock57
Shares of Ceres, Inc. (CERE) surged $0.04 (or +17.67%) to $0.28 on Friday's trading session, after the company reported favorable results from its biotech corn evaluations in China.

CERE said that its multi-gene combinations in corn achieved an approximately 25% yield advantage over controls in many of its research-scale field evaluations involving two different hybrids.

Field evaluations represent a critical stage in the development of biotech crop traits, as they provide greater insight into how traits may perform in an agricultural setting.

The company's strategy is to focus on optimized gene combinations that can show large, step increases in trait performance. CERE's scientists believe that combining genes together, to either create a stronger trait or combine complementary traits, provides the best approach to generate high impact advantages, such as increased grain yield or drought tolerance

Corn is the most widely produced feed grain in the United States. According to CERE, at today's corn prices and acreage in North America, a 1% increase in yield is worth over a half-billion dollars annually at the farm gate. Corn provides an additional out-licensing opportunity for traits that CERE is developing for use in sorghum and other crops.

CERE is an agricultural biotechnology company that develops and markets seeds to produce crops for bioenergy and other markets that utilize plant biomass. CERE combines advanced plant breeding and biotechnology to develop hybrids that can address the limitations of first-generation bioenergy feedstocks. These technology platforms, which can increase crop productivity, improve quality, reduce crop inputs and improve cultivation on marginal land, have broad application across multiple crops, including food, feed, fiber and fuel crops.

More about Ceres, Inc. (CERE) at www.ceres.net

**

Origin Agritech Limited (SEED) stock closed at $1.44, up $0.09 (or +6.67%), and 54,263 of its shares were traded on Friday's market activity.

SEED recently has received the renewed Bio-safety Certificate from the Ministry of Agriculture for its genetically modified phytase corn.

Genetically modified (GM) seed products in China must undergo five separate stages of approval beginning with a phase one laboratory approval to the final receipt of the Bio-safety Certificate in phase five. Bio-safety Certificate has an effective period of five years and the Ministry of Agriculture may review additional data for safety evaluations during the renewal application process.

According to SEED, in fiscal year 2014 the company further advanced its GM corn seed pipeline with several generations of GM technologies and in addition to its progress with the regulatory approvals, SEED has made significant progress in the backcrossing of its GM traits into its hybrid corn varieties.

SEED said that period was a transition year for both the agricultural biotechnology and conventional seed industries in China. For the genetically modified technologies, there are indications that the Chinese government is starting to promote Genetically Modified (GM) technologies and is trying to educate the public about the safety of these technologies.

On its unaudited financial results for fiscal 2014, SEED posted total revenues of RMB414.89 million (US$67.52 million), a decrease of 14% versus fiscal 2013, mainly due to the lower sales for the Company's rice seed business and a decline in the corn seed contract production businesses.

On the operating improvement front SEED was able to overcome the challenges in one of the worst years in the seed industry by significantly reducing the operating costs, increasing sales volume of its corn seed business, and managing its inventory reduction efforts.

SEED is China's leading agricultural biotechnology company, specializing in crop seed breeding and genetic improvement, seed production, processing, distribution, and related technical services. Leading the development of crop seed biotechnologies, SEED's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture.

More about Origin Agritech Limited (SEED) at www.originseed.com.cn/en

**

Crown Equity Holdings Inc. (CRWE) is currently developing its CRWE Network ( www.CRWE-PR.com ), a growing network of community targeted sites.

It has recently included Huntington Beach ( www.huntingtonbeach.crwe-pr.com ), a seaside city within Orange County in Southern California to the CRWE Network.

Huntington Beach is bordered by the Pacific Ocean on the west, and has been long known for its long 9.5-mile (15.3 km) stretch of sandy beach, mild climate, and excellent surfing, earning it the nickname of Surf City.

Companies employing more than 500 workers in Huntington Beach include Boeing, Quiksilver, Cambro Manufacturing, Dynamic Cooking Systems, C&D Zodiac, Inc., Triad Financial, E-Trade Mortgage and Huntington Beach Hospital.

The City of Huntington Beach had an estimated population in 2013 (U.S. Census Bureau) of 197,575, and represents an important marketplace for the CRWE Network, which business model is based on selling advertising to businesses targeting both locally and nationally

The CRWE Network has reached the 1487th community website in the U.S., associated with 3456 ZIP Codes, and includes coverage in the states of California, Mississippi, Michigan, Florida, Nevada and New York, as well as across 10 provinces in Canada.

CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com

**

Disclaimer: CRWE-PR Finance ( www.finance.crwe-pr.com ) is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE-PR Finance www.finance.crwe-pr.com/disclaimer

Cerevel Therapeutics Holdings, Inc. (CERE) Stock Research Links

CERE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DayOne's Bold Energy Moves With Sembcorp for Asia Growth

Updated Category News Views 79

It seems the digital world and power supply have locked in a new dance as DayOne Data Centers teams up with Sembcorp Utilities. It's high time we gave this story a solid look, especially with data centers gobbling energy faster than my old trading partner downs an espresso. Tackling Energy Constraints Head-On The digital infrastructure beast is hungry for power, and...

Continue Reading
Jack Henry's Q1 2027 Deconversion Revenue Hits $17.9M

Updated Category News Views 30

Jack Henry Surprises with Strong Deconversion Revenue You're probably thinking, deconversion revenue—what on earth is that? Imagine you're in the financial tech business and one of your bigwig clients decides to merge or get gobbled up by another institution. They move shop, and voila, you've got some unexpected money flowing in due to that exit. That's deconversion...

Continue Reading
Young Leaders Drive Be Strong’s Mental Health Movement

Updated Category News Views 50

New Voices at the Helm Today’s youth aren’t just tomorrow's leaders; they’re stepping up now. Groups like Be Strong’s newly minted National Student Advisory Board are proving that. Sixteen kids across eleven states are diving headfirst into transforming mental health narratives. This ain't just some school club. These young guns are gearing up to reshape how we...

Continue Reading
Spotting Alzheimer's: Holiday Visits Might Reveal More

Updated Category News Views 34

The Unspoken Truth of Holiday Reunions Is there any better barometer than a holiday visit to gauge how your parents are truly doing? Most of us are zooming in, lugging our baggage through the front door and finding Dad telling the same old story not once, not twice, but three solid times at the table. Then there’s Mom, fumbling her way through that pie recipe she could...

Continue Reading
Yale's $10M Inflammation Initiative: Future Health Impact

Updated Category News Views 45

Yale’s Inflammation Research: Beyond the Basics Inflammation. It’s the kind of battle your own body wages from within, and Yale School of Medicine’s fresh $10 million grant from the Blavatnik Family Foundation means they’re marching deeper into the trenches. This is not another academic exercise; it’s about digging out the roots of diseases that are tough to pin...

Continue Reading
CloudKeeper Simplifies AI Cost Tracking with FinOps Launch

Updated Category News Views 43

AI Cost Management: A Complex Endeavor Tracking the myriad costs of AI operations can be downright infuriating. Every company dipping its toes in these waters quickly finds itself tangled in a web of fees spanning different models, applications, and cloud services. This tangled mess is about to get some much-needed untangling, thanks to CloudKeeper's latest move. They're...

Continue Reading
Quanta Services Reports Record Q3 2026 Earnings

Updated Category News Views 79

Quanta Services Smashes Q3 2026 Expectations If you're a stakeholder in Quanta Services, you'd probably be dancing in the aisles right now. This company just posted off-the-charts numbers for the third quarter of 2026. We're talking revenues of $12 billion—a staggering leap from $7.63 billion the same quarter last year. Explosive Earnings and Strong Backlog The star of...

Continue Reading
Wabi's $1.25B Valuation: A New Era for AI?

Updated Category News Views 155

A Major Milestone for Wabi Well, here we go—Wabi, the brainchild of Eugenia Kuyda, is stirring the pot with a massive $55 million funding round, pulling its valuation up to a hefty $1.25 billion. If you're raising eyebrows at that price tag, you’re not alone. It's a big number riding on an even bigger idea: that AI isn't just for solitary chats anymore, but for...

Continue Reading
ACTEC Welcomes 55 New Fellows: A Closer Look

Updated Category News Views 99

Coffee's brewing hot, and so are the stakes at ACTEC, where 55 new Fellows just got the nod. The American College of Trust and Estate Counsel isn't your average club. They've been at this game since 1949, bringing together the finest minds in trusts and estates. But what does this newest batch bring to the table, and why should investors take a moment to notice? A Diverse...

Continue Reading
Static Media Acquires CarScoops to Boost Auto Reach

Updated Category News Views 74

Static Media's Latest Move in the Automotive Arena The digital media landscape keeps morphing, and Static Media just decided to crank up the gears a notch by snapping up CarScoops.com. For those with an eye on the automotive field, it's the kind of play that could shift the tides. Static Media, already a heavyweight with brands like Jalopnik and SlashGear under its belt,...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Action Against Jetstar for Misleading Passenger Rights

Updated Category News Views 207

Legal Action Against Jetstar for Misleading Passenger Rights New Zealand's competition authority is taking serious action against Jetstar, a low-cost airline operating under Qantas. They're in court over allegations that Jetstar misled its passengers about their rights to compensation due to delayed and cancelled flights. Allegations of Misleading Practices The New...

Continue Reading
Loona Petbot Commemorates Anniversary with User Engagement Surge

Updated Category News Views 197

Loona Petbot Commemorates Anniversary with Impressive User Engagement KEYi Technology is excited to share the remarkable success of its 1000-day anniversary celebration of the Loona Petbot. This event commenced recently and received an overwhelming response from users around the world. More than ten thousand participants engaged in the celebrations, showcasing the growing...

Continue Reading
Exploring Royce Small-Cap Trust: Current Insights and Trends

Updated Category News Views 145

Introduction to Royce Small-Cap Trust Royce Small-Cap Trust (NYSE: RVT) stands as a prominent name in the small-cap investment landscape, renowned for its commitment to long-term capital growth. Established as one of the oldest and largest closed-end funds focused on small-cap and micro-cap securities, this trust has carved a niche for itself among investors seeking...

Continue Reading
Grace Hill Teams with IWBI to Advance WELL Workspaces

Updated Category News Views 8

Pushing the Boundaries of Building Health The workplace is evolving, pal, and it ain't the stodgy cubicle farm it once was. Grace Hill, the technological maestro of real estate performance solutions, has shaken hands with the International WELL Building Institute (IWBI). This move ain't just about pushing a few papers but about bringing the occupant experience front and...

Continue Reading
Oppenheimer Upholds Outperform Rating for Tarsus Pharmaceuticals

Updated Category News Views 63

Oppenheimer Reaffirms Positive Outlook on Tarsus Pharmaceuticals Recently, Oppenheimer reiterated its favorable stance on Tarsus Pharmaceuticals (NASDAQ:TARS), affirming an Outperform rating coupled with a price target of $63. This endorsement comes ahead of the company's anticipated financial report for the third quarter of 2024, with special attention on the performance...

Continue Reading